MoneyWorks4Me

Thyrocare Technologies informs about analyst meet

08 Feb 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a conference call for the Indian and overseas analysts is arranged by management to discuss the Company's unaudited financial results Quarter / Nine Months ended December 31, 2017, on Friday, February 09, 2018 at 2.30 pm local time. Dr Velumani A., Ph.D., CEO, A. Sundararaju, CFO, Sachin Salvi, GM-Finance and Vatsal Goyal- Head- Strategy and Corporate Development, will represent the Company.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

618.25 -5.55 (-0.89%)
17-Aug-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: